Page last updated: 2024-10-21

phenytoin and Anti-Glomerular Basement Membrane Disease

phenytoin has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies

Anti-Glomerular Basement Membrane Disease: An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.

Research Excerpts

ExcerptRelevanceReference
" A 35-year-old man who had been taking a low dose of phenytoin for epilepsy presented with nephrotic syndrome and a mesangiocapillary glomerulonephritis."3.66Plasma exchange in the successful treatment of drug-induced renal disease. ( Short, AI; Swainson, CP; Thomson, D; Winney, RJ, 1982)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Swainson, CP1
Thomson, D1
Short, AI1
Winney, RJ1

Other Studies

1 other study available for phenytoin and Anti-Glomerular Basement Membrane Disease

ArticleYear
Plasma exchange in the successful treatment of drug-induced renal disease.
    Nephron, 1982, Volume: 30, Issue:3

    Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antigen-Antibody Complex; Female; Glomerulonephrit

1982